Transtek(SZ:300562) Zheng Quan Zhi Xing·2025-08-15 12:16Summary of Key Points Core Viewpoint The report outlines the management, storage, and usage of the funds raised by Guangdong Leshi Medical Electronics Co., Ltd. for the first half of 2025, detailing the total amount raised, the current balance, and the specific projects funded. Fundraising Overview - The company raised a total of RMB 385,356,068.13 by issuing 23,998,780 shares at a price of RMB 16.48 per share to 14 specific investors [1][2] - As of the end of 2024, the balance in the fundraising special account was RMB 190,328,551.27, with RMB 9,537,660.29 used in the current year, leaving a balance of RMB 182,230,103.57 as of June 30, 2025 [2][5] Fund Management - The company has established a fundraising management system to enhance the efficiency of fund usage, complying with relevant regulations [2][3] - Funds are stored in special accounts at various banks, including China Construction Bank and Bank of China, specifically for the purpose of managing the raised funds [3][4] Fund Usage - The actual usage of the raised funds for the first half of 2025 is detailed in an attached table, with no changes in project implementation locations or methods reported [7][8] - The company has approved the use of up to RMB 180 million of idle funds for cash management, investing in safe and liquid financial products [7][8] Project Adjustments - The company has decided to extend the timeline for certain projects, such as the "Smart Blood Glucose Monitoring Product Industrialization Project," to October 31, 2026, due to market conditions and operational needs [8][10] - The remaining RMB 5,627.60 million from the "TWS Earphone Production Line Construction Project" will be used for permanent working capital [10][12] Compliance and Reporting - The company confirms that there are no issues with the disclosure of fundraising usage, and all activities comply with regulatory requirements [8][9] - The report was approved by the board of directors on August 14, 2025 [8]